Skip to content

Optimizing the Care Pathway of Febrile Children Via Capillary C-reactive Protein Assay in Primary Care

Optimisation du Parcours de Soins Des Enfants fébriles Par l'Utilisation de la CRP Capillaire en Soins Primaires : Protocole d'un Essai Multicentrique randomisé

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT06910631
Acronym
CRP-CAP
Enrollment
420
Registered
2025-04-04
Start date
2025-09-15
Completion date
2027-06-01
Last updated
2026-06-23

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Fever

Keywords

C-reactive protein

Brief summary

Fever is the leading reason for outpatient consultations among children aged 2 to 9 years. The main concern in fever is severe bacterial infection, particularly for younger children. History and clinical examination do not always differentiate viral infections from bacterial infection. In 20% of febrile children, no infectious focus is found after examination and additional tests are necessary. The first one is measuring C-reactive protein (CRP). The results are obtained in several hours on an outpatient basis, causing long delays before starting treatment and often requiring telephone calls or further consultations. Emergency room use is constantly increasing, generating growing tensions within healthcare facilities, yet a large number of visits are avoidable. Among children visiting the pediatric emergency room, parents reported being referred by their primary care physician in approximately 20% of cases for children aged 1 to 5 years and in 30% of cases for children under one year old. The use of capillary medical device to measure CRP in primary care could reduce this referral rate and help relieve overcrowding in emergency rooms, as well as unscheduled consultation centers and medical analysis laboratories. This would result in a streamlined care pathway, saving time for both physicians and patients, as well as reducing the cost of care for the healthcare system.

Interventions

OTHERCapillary CRP

CRP measured semi-quantitatively using ACTIM-CRP device

Sponsors

Centre Hospitalier Universitaire de Nīmes
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
SINGLE_GROUP
Primary purpose
OTHER
Masking
SINGLE (Outcomes Assessor)

Intervention model description

Cluster randomized step wedge

Eligibility

Sex/Gender
ALL
Age
3 Months to 15 Years
Healthy volunteers
No

Inclusion criteria

* The patient must be a member or beneficiary of a health insurance plan * Children consulting primary health institutes with fever (temperature ≥ 38°C) requiring CRP testing: * Fever \> 12h in infants aged 3 to 6 months * Fever ≥ 5 days in children over 6 months of age * Fever \>12h regardless of age, and at the time of consultation, the doctor is concerned about the child's general condition, the tolerance of the fever, or doubts about a bacterial focus (e.g. suspicion of pneumopathy, appendicitis, etc.). * No severity criteria necessitating immediate hospitalization * No bacterial infection whose diagnosis is exclusively clinical or identified by other means (e.g. purulent AOM, bacterial angina identified by RDT, etc.). * Child whose parents and child have been informed about the study, and at least one parent has given consent for their child's participation in the study. * Enrolment of the child according to their capacity of discernment (for children aged 12 and over, enrolment is essential). * Child affiliated to or benefiting from a health insurance scheme

Exclusion criteria

* The subject is participating in a category 1 interventional study, or a study with drug or medical device * Premature infants under one year of age * Immunosuppression * Sunstroke * Chronic infection * Malignant pathology * Autoimmune pathology * Sickle cell disease * Child with a central catheter

Design outcomes

Primary

MeasureTime frameDescription
Referral rates to any facility equipped for emergency laboratory testing between conditionsDay 1Referral: Yes/No as reported by the physician

Secondary

MeasureTime frameDescription
Referral rates to medical biology laboratories between conditionsDay 1Referral: Yes/No as reported by the physician
Referral rates to emergency departments between conditionsDay 1Referral: Yes/No as reported by the physician
Number complementary tests between conditionsDay 1Total number of tests as reported by the physician
Type of complementary tests between conditionsDay 1Qualitative listing of all further tests classified as: biological (CBC, venous CRP, iono/creatininemia, liver function tests, ECBU, others) or imaging (chest X-ray, abdomino-pelvic ultrasound, urinary and renal ultrasound) as reported by the physician
GP satisfaction on care organizationDay 70-10 visual analog scale
The total duration of GP time between conditionsDay 7Minutes: measured as consultation time + examination time and time to inform the family
Parent satisfaction with the care pathwayDay 70-10 numeric scale
Rate of antibiotic prescription between conditionsDay 1Antibiotic prescription: Yes/No as reported by the physician
Duration of fever episode between groupsDay 7Days counted upon reaching 24 hours without fever
Cost-consequences between groupsDay 7euros
Budget impact analysisDay 7euros

Countries

France

Contacts

CONTACTChloé SIKIRDJI
chloe.sikirdji@umontpellier.fr06.15.56.80.28
PRINCIPAL_INVESTIGATORChloé SIKIRDJI

Centre Hospitalier Universitaire de Nīmes

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Jun 24, 2026